LEADER 01522oam 2200421Ka 450 001 9910698551403321 005 20150611164806.0 035 $a(CKB)3640000000034031 035 $a(OCoLC)78615707 035 $a(EXLCZ)993640000000034031 100 $a20070117d2006 ua 0 101 0 $aeng 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNew malignancies among cancer survivors$b[electronic resource] $eSEER cancer registries, 1973-2000 /$fedited by Rochelle E. Curtis ... [and others] 210 1$a[Bethesda, Md.] :$c[National Cancer Institute, U.S. Dept. of Health and Human Services, National Institutes of Health],$d[2006] 215 $aviii, 492 pages $cdigital, PDF file 225 1 $a[NIH publication ;$vno. 05-5302] 300 $aTitle from title screen (viewed on Aug. 19, 2008). 320 $aIncludes bibliographical references. 517 $aNew Malignancies Among Cancer Survivors 606 $aCancer$xRelapse$zUnited States$vStatistics 606 $aCancer$xReporting$zUnited States 606 $aCancer$zUnited States$vStatistics 608 $aStatistics.$2lcgft 615 0$aCancer$xRelapse 615 0$aCancer$xReporting 615 0$aCancer 701 $aCurtis$b Rochelle E$01400135 712 02$aNational Cancer Institute (U.S.) 801 0$bGPO 801 1$bGPO 801 2$bGPO 906 $aBOOK 912 $a9910698551403321 996 $aNew malignancies among cancer survivors$93466530 997 $aUNINA LEADER 01061nam 2200361 450 001 9910812857903321 035 $a(CKB)3710000001083280 035 $a(MiAaPQ)EBC4810616 035 $a(EXLCZ)993710000001083280 100 $a20170307h20152015 uy 0 101 0 $adut 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aFarmacologie voor vroedvrouwen $eleidraad voor opleiding en dagelijkse praktijk /$fDr. G. Faron, Dr. D. Bayot 205 $aTweede editie. 210 1$aBrussels, Belgium :$cAcademic and Scientific Publishers,$d2015. 210 4$dİ2015 215 $a1 online resource (224 pages) 300 $aIncludes index. 606 $aObstetrical pharmacology 615 0$aObstetrical pharmacology. 676 $a618.2061 700 $aFaron$b G.$01697707 702 $aBayot$b D. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910812857903321 996 $aFarmacologie voor vroedvrouwen$94078632 997 $aUNINA